Literature DB >> 3793008

A histological study of hepatitis delta virus liver disease.

G Verme, P Amoroso, G Lettieri, P Pierri, E David, F Sessa, R Rizzi, F Bonino, S Recchia, M Rizzetto.   

Abstract

The histopathology of hepatitis delta virus disease was studied in carriers of HBsAg with chronic hepatitis delta antigen-positive hepatitis and in serial biopsies of patients with acute hepatitis delta virus hepatitis that progressed to chronicity. There was no histologic feature distinctive of hepatitis delta virus from other types of viral hepatitis. Biopsy specimens of patients with chronic disease exhibited portal and periportal inflammation with piecemeal necrosis, conforming to a picture of aggressive hepatitis often accompanied by cirrhosis. Characteristic was a marked intralobular infiltration by mononuclear cells and a degenerative eosinophilic change of the hepatocytic cytoplasms conducive to the formation of acidophilic bodies. Liver specimens from patients with hepatitis delta virus hepatitis exhibited aspects of focal, confluent and bridging necrosis. The disease progressed to chronicity irrespective of the original histological features. The expression of intrahepatic hepatitis delta antigen was reduced in the phase of the acute hepatitis but increased in parallel with the development of chronic active liver disease. In late-stage cirrhosis, expression of hepatitis delta antigen was usually low.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3793008     DOI: 10.1002/hep.1840060613

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  13 in total

1.  Peliosis hepatis and sinusoidal dilation during infection by the human immunodeficiency virus (HIV). An ultrastructural study.

Authors:  J Y Scoazec; C Marche; P M Girard; J Houtmann; A M Durand-Schneider; A G Saimot; J P Benhamou; G Feldmann
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

Review 2.  Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options.

Authors:  Florian A Lempp; Yi Ni; Stephan Urban
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-08-18       Impact factor: 46.802

3.  Experimental transmission of human hepatitis delta virus to the laboratory mouse.

Authors:  H J Netter; K Kajino; J M Taylor
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

4.  In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.

Authors:  Bruno B Bordier; Junko Ohkanda; Ping Liu; So-Young Lee; F H Salazar; Patricia L Marion; Kazuo Ohashi; Leonard Meuse; Mark A Kay; John L Casey; Said M Sebti; Andrew D Hamilton; Jeffrey S Glenn
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 5.  Delta and non-A, non-B hepatitis viruses.

Authors:  F Bonino; M Baldi; A Demartini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

6.  Expression of intrahepatic hepatitis D viral antigen in chronic hepatitis D virus infection.

Authors:  J Y Lau; L J Hansen; V G Bain; K Chaggar; H M Smith; B C Portman; D Vergani; G J Alexander; R Williams
Journal:  J Clin Pathol       Date:  1991-07       Impact factor: 3.411

7.  A genotype of hepatitis D virus that occurs in northern South America.

Authors:  J L Casey; T L Brown; E J Colan; F S Wignall; J L Gerin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

8.  TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection.

Authors:  Carla Usai; Sheila Maestro; Gracian Camps; Cristina Olague; Lester Suárez-Amaran; Africa Vales; Tomas Aragon; Mirja Hommel; Rafael Aldabe; Gloria Gonzalez-Aseguinolaza
Journal:  JHEP Rep       Date:  2020-03-10

Review 9.  The oncogenic role of hepatitis delta virus in hepatocellular carcinoma.

Authors:  Marc Puigvehí; Carlos Moctezuma-Velázquez; Augusto Villanueva; Josep M Llovet
Journal:  JHEP Rep       Date:  2019-05-16

Review 10.  Hepatitis delta: virological and clinical aspects.

Authors:  Luan Felipo Botelho-Souza; Mariana Pinheiro Alves Vasconcelos; Alcione de Oliveira Dos Santos; Juan Miguel Villalobos Salcedo; Deusilene Souza Vieira
Journal:  Virol J       Date:  2017-09-13       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.